Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
about
Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7.The human keratins: biology and pathology.Metachronous metastasis from the right colon adenocarcinoma to the vulva: an unusual report and literature review.Image guided biopsy in the management of cancer of the ovary.Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia.Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomasBasal cell-specific and hyperproliferation-related keratins in human breast cancerCytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodiesKeratin expression in cervical cancer.Changes in expression of differentiation markers between normal ovarian cells and derived tumors.Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20.Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis.Ultrastructure of ectopic peritoneal lesions from women with endometriosis, including observations on the contribution of coelomic mesotheliumImmunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approachMultiple primary cancers of the colon, rectum, and the thyroid glandCytokeratin intermediate filament expression in benign and malignant breast disease.Neuropathology of brain metastases.The OV-TL 12/30 clone of anti-cytokeratin 7 antibody as a new marker of corneal conjunctivalization in patients with limbal stem cell deficiency.Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate.Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.Altered expression of cytokeratin 7 and CD117 in transitional mucosa adjacent to human colorectal cancer.The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cellsA novel monoclonal antibody to cytokeratin 18 with reactivity toward lung squamous cell carcinomas and adenocarcinomas of various sites.Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins.Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa.Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations.Protein and mRNA expression of simple epithelial keratins in normal, dysplastic, and malignant oral epithelia.The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer.Establishment and characterization of five new human renal tumor xenografts.
P2860
Q24299967-0C260D52-E99C-48D9-A0DA-C5C38DEDA933Q34776574-4FC9764A-139A-47C1-8C2A-5EE18E907A98Q35144817-D6D71888-516A-4344-9ABC-6C1228DAA40BQ35214854-FCEF0901-0B47-49CC-86BA-A33D8DBCFF56Q35830638-C04E829D-76BD-474B-B18E-F8A363804B04Q35830745-F013CB00-E5B5-4677-BF39-62B3BBC41CFFQ35831039-89A9868C-ED33-42ED-B3D7-22C1E6B46989Q35831412-03A9D923-121D-48F2-8C47-31EAE6798839Q35831960-B5F4582C-16AE-48AA-9FB3-C75C328D80B6Q35832568-0232E979-04E1-4E32-BDBD-36F00129B287Q36431201-051F1DB2-D64F-4D90-BC79-FC1700549ACDQ36627144-A048443A-7627-45CE-B3E3-1B4B911EC9E7Q37140910-22724FD9-1A96-45A4-807A-F2CC1FD2ADCFQ37236418-8F987F49-3D70-490F-961A-A607D5ED2697Q37243599-16E31462-4E1C-4B4F-B8A8-ABAADF699E2BQ37255237-E922C70C-2458-498A-952E-B2ECF3E7D11BQ38110295-259400AC-3911-4D11-814C-DB1678DB54EDQ38516906-205B1F1D-A5C3-4273-B2BF-B16AD1CA7AA6Q39658417-8B2841B7-C5D3-4BC9-BB72-7F8125F32ADBQ39706806-70502338-6598-4B99-B59E-77BF6C466F9CQ40978030-692B0E36-2C32-4B9C-9148-90F5E605D35DQ41450034-A36F6493-F0D5-4192-9B0C-88E67EB3BF77Q41626789-9074997B-C07C-4C38-A3F4-0CE0AFA9A601Q41856635-359C187A-EB46-468E-BADA-D9A73A55CDA5Q41856934-BA152DEE-EECA-46FF-A3DA-5DF734BB41F2Q41869135-3C9365C8-8A01-4EE2-BF3D-3C18B8841C14Q42112184-EE88D656-39DD-4ABA-AAA3-4690228329D0Q42476765-1A329FFD-6FAC-411A-A1BE-F31A939DE95BQ42536189-3D8E7EF1-C0E1-467F-9D1A-16D6D3DF6247Q42586887-4208F0E1-A990-4415-B579-B721F2DA0A5CQ42755804-8A00E523-C074-42E5-956B-4EED5E4656F0
P2860
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@ast
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@en
type
label
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@ast
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@en
prefLabel
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@ast
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@en
P2093
P2860
P1476
Use of monoclonal antibodies t ...... diagnosis of adenocarcinomas.
@en
P2093
Huijsmans A
Ramaekers F
Schaafsma E
van Niekerk C
P2860
P304
P407
P577
1990-03-01T00:00:00Z